Stathmin expression alters the antiproliferative effect of eribulin in leiomyosarcoma cells

• Main Authors: Mana Azumi (Author), Mikihiro Yoshie (Author), Nami Nakachi (Author), Atsuya Tsuru (Author), Kazuya Kusama (Author), Kazuhiro Tamura (Author)
• Format: Book
• Published: Elsevier, 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Uterine leiomyosarcoma is an aggressive soft tissue tumor. Stathmin, a phosphoprotein that modulates microtubule dynamics, is highly expressed in many malignancies including leiomyosarcoma. The microtubule-depolymerizing agent eribulin has been recently approved for treating malignant soft tissue tu...